WHO ICTRP trial
Investigating the safety and tolerability of ONC201 in healthy adults under…
ACTRN12621000975897 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12621000975897 |
|---|---|
| Public title | Investigating the safety and tolerability of ONC201 in healthy adults under fasting and fed conditions |
| Scientific title | A Phase 1, randomized study to evaluate the safety, tolerability, and pharmacokinetics (PK) of ONC201 and the effects of food on the bioavailability of ONC201 following oral administration in healthy adult subjects |
| Primary sponsor | Chimerix, Inc. |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | New Zealand |
| Conditions | Cancer; Cancer;Cancer - Brain |
| Interventions | Part B1 - participants will randomly receive each of the following single-dose treatments,in a randomised sequence, over the course of 3 treatment periods with a washout interval between doses of at least 7 days: • Treatment A: 125 mg… |
| Registration date | Jul 26, 2021 |
| Target size | 18 |
| Secondary IDs | ONC201-101 - Part B1 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: